Thyroid cancer: pathogenesis and targeted therapy

DA Liebner, MH Shah - Therapeutic advances in …, 2011 - journals.sagepub.com
Therapeutic options for advanced, unresectable radioiodine-resistant thyroid cancers have
historically been limited. Recent progress in understanding the pathogenesis of the various …

Thyroid cancer: pathogenesis and targeted therapy

DA Liebner, MH Shah - Therapeutic advances in …, 2011 - pubmed.ncbi.nlm.nih.gov
Therapeutic options for advanced, unresectable radioiodine-resistant thyroid cancers have
historically been limited. Recent progress in understanding the pathogenesis of the various …

Thyroid cancer: Pathogenesis and targeted therapy

DA Liebner, MH Shah - Therapeutic Advances in …, 2011 - ohiostate.elsevierpure.com
Therapeutic options for advanced, unresectable radioiodine-resistant thyroid cancers have
historically been limited. Recent progress in understanding the pathogenesis of the various …

[HTML][HTML] Thyroid Cancer: Pathogenesis and Targeted Therapy

DA Liebner, MH Shah - Therapeutic Advances in Endocrinology …, 2011 - ncbi.nlm.nih.gov
Therapeutic options for advanced, unresectable radioiodine-resistant thyroid cancers have
historically been limited. Recent progress in understanding the pathogenesis of the various …

Thyroid cancer: pathogenesis and targeted therapy.

DA Liebner, MH Shah - Therapeutic Advances in Endocrinology …, 2011 - europepmc.org
Therapeutic options for advanced, unresectable radioiodine-resistant thyroid cancers have
historically been limited. Recent progress in understanding the pathogenesis of the various …

Thyroid cancer: pathogenesis and targeted therapy.

DA Liebner, MH Shah - Therapeutic Advances in Endocrinology …, 2011 - europepmc.org
Therapeutic options for advanced, unresectable radioiodine-resistant thyroid cancers have
historically been limited. Recent progress in understanding the pathogenesis of the various …